Medicinal cannabis in children and adolescents with autism spectrum disorder: A scoping review.

Sarah FletcherColleen PawliukAngie IpLinda HuhShahrad Rod Rassekh Tim F Oberlander Harold Siden

Published in: Child: care, health and development (2021)

Early reports regarding medicinal cannabis in paediatric ASD symptom management are presented as positive; the evidence, however, is limited to very few retrospective cohort and observational studies. Evidence of safety and efficacy from prospective clinical trials is needed.

Keyphrases

clinical trial
autism spectrum disorder
intensive care unit
emergency department
attention deficit hyperactivity disorder
intellectual disability
randomized controlled trial
open label
phase ii
working memory